99% Savings - Buy Just @1 Rs X
Myezom 3.5 Injection is a prescription medicine that is available as a Injection. It is primarily used for the treatment of Multiple Myeloma. Other than this, Myezom 3.5 Injection has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Myezom 3.5 Injection depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Myezom 3.5 Injection as well, which are listed below. Normally, these side effects of Myezom 3.5 Injection are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Myezom 3.5 Injection has a Severe effect for pregnant women and Severe effect on lactating mothers. Further, the section on Myezom 3.5 Injection related warnings talks about Myezom 3.5 Injection's effects on the liver, heart and kidney.
Myezom 3.5 Injection is contraindicated in people with pre-existing medical conditions like Gastrointestinal Bleeding as it can result in adverse effects. Other conditions have been mentioned below in the Myezom 3.5 Injection contraindications section.
Besides this, Myezom 3.5 Injection may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Myezom 3.5 Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Myezom 3.5 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Myezom 3.5 Injection safe for pregnant women?
Myezom can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Myezom 3.5 Injection safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Myezom. It should only be taken after medical advice.
What is the effect of Myezom 3.5 Injection on the Kidneys?
Using Myezom does not have any harmful effects on kidneys.
What is the effect of Myezom 3.5 Injection on the Liver?
There may be an adverse effect on the liver after taking Myezom. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Myezom 3.5 Injection on the Heart?
There may be an adverse effect on the heart after taking Myezom. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
If you are suffering from any of the following diseases, you should not take Myezom 3.5 Injection unless your doctor advises you to do so -
Is this Myezom 3.5 Injection habit forming or addictive?
Myezom 3.5 Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Myezom 3.5 Injection you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Myezom 3.5 Injection is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Myezom 3.5 Injection for mental disorders.
Interaction between Food and Myezom 3.5 Injection
Taking Myezom 3.5 Injection with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Myezom 3.5 Injection
Due to lack of research, there is no information about the side effects of taking Myezom 3.5 Injection with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 234-235
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 871
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Velcade® (bortezomib)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Bortezomib Aft (Bortezomib)